PEAK6 Investments LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 72 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.

Quarter-by-quarter ownership
PEAK6 Investments LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2019$5,849,000
-6.6%
51,100
-22.2%
0.04%
-11.9%
Q2 2019$6,261,000
+32.2%
65,700
+26.6%
0.04%
+50.0%
Q1 2019$4,736,000
+75.6%
51,900
+46.1%
0.03%
+64.7%
Q4 2018$2,697,00035,5250.02%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 149,457$11,773,0006.29%
INDUS CAPITAL PARTNERS, LLC 330,339$26,021,0002.54%
Perpetual Ltd 129,799$10,215,0001.32%
Black Creek Investment Management Inc. 396,525$31,234,0001.18%
RUDMAN ERROL M 28,701$2,261,0001.10%
COMGEST GLOBAL INVESTORS S.A.S. 635,752$50,078,0001.09%
Antipodean Advisors LLC 15,000$1,182,0000.96%
Hillhouse Capital Management 618,391$48,711,0000.83%
JUPITER ASSET MANAGEMENT LTD 215,866$17,004,0000.49%
Temasek Holdings (Private) Ltd 990,000$77,982,0000.48%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders